Thermo Fisher Scientific, Inc. (US), Charles River Laboratories International, Inc. (US), Merck KGaA (Germany), Laboratory Corp Of America Holdings (US), and Eurofins Scientific (Germany), are the Leading Players in the Genetic Toxicology Testing Market
The genetic toxicology testing market is projected to reach USD 2.0 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 10.2% during the forecast period. The increased pharmaceutical research activities, opposition to animal testing, and R&D on early toxicity detection are the primary growth factors for this market. Also, the increasing focus on drug discovery and personalized medicine using in vitro methods, and the rising demand for humanized animal models are expected to offer significant opportunities for market growth in the coming years. However, the failure to establish the intricacies of in vivo conditions, lack of in vitro models to study complex endpoints, and the reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy are expected to restrain market growth to a certain extent.
The global genetic toxicology testing market is consolidated at the top, with a large number of leading market players based in developed countries. The prominent players in this market are Thermo Fisher Scientific Inc. (US), Charles River Laboratories International, Inc. (US), Creative Bioarray (US), Laboratory Corp Of America Holdings (US), Jubilant Life Sciences Limited (India), Cyprotex PLC (UK), Merck KGaA (Germany), Shanghai Medicilon Inc. (China), Eurofins Scientific (Germany), Creative Biolabs (US), Toxikon Corporation (US), Environmental Bio-Detection Products Inc. (EBPI) (Canada), Gentronix Limited (UK), MB Research Laboratories (US), and Sotera Health LLC (US). However, in the last few years, a number of smaller players have emerged from niche markets and are competing with global players based on price and technological innovation. Due to the intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into high-growth emerging markets and strengthening their technological competitiveness in the market by acquiring smaller players with desired technological capabilities or geographic presence.
To know about the assumptions considered for the study. download the pdf brochure
Thermo Fisher Scientific is one of the leading players in the genetic toxicology testing market. The company is known for its diversified product offerings in the toxicology arena ranging from DNA damage assays, micronucleus reagents kits, genotoxicity panels, and quantification assay kits along with a wide range of customization services. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, the large number of production sites gives it a competitive advantage over other players in the genetic toxicology testing market.
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions worldwide accelerate their research and drug development efforts. Charles River, with its extensive product and service range, is a leading solutions provider in the genetic toxicology market. With a presence across more than 100 countries, Charles River provides core genotoxicology assays to pharmaceutical and biopharmaceutical sectors.
LabCorp’s CDD business segment is responsible for providing end-to-end drug development services, from early-stage research to clinical trial management. CDD’s preclinical service offerings include research models, lead optimization, analytical services, safety assessment, and chemistry manufacturing and control (CMC) services for drug development. It offers several toxicology services involving in vitro and in vivo testing, such as general toxicology studies, genetic toxicology studies, neurotoxicology studies, immunotoxicology studies, juvenile toxicology studies, lead optimization non-GLP toxicology, and developmental & reproductive toxicology (DART). Apart from pharmaceutical in vitro toxicology testing, Covance also offers in vitro toxicology tests for the agriculture, biotechnology, and food services industries.
Related Reports:
Genetic Toxicology Testing Market by Product (Assays, Reagents & Consumables, Services), By Application (Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry), COVID-19 Impact - Global Forecast to 2025
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
